ONC001 is a first-in-class antibody-drug conjugate (ADC) designed to uniquely target CD64, a myeloid-restricted receptor pervasively expressed in CMML and M4/M5 acute myeloid leukemia, including ...
Delve into Vandria's technology and its Alzheimer's candidate, VNA-318, the first mitophagy-based candidate in Alzheimer's in ...
Preliminary clinical evidence of Lisaftoclax overcoming venetoclax resistance in myeloid malignancies with a 31.8% overall ...
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed AML ...
An updated Canadian guideline on HIV prevention addresses the expanding range of medications available to reduce the risk of ...
While pharmaceutical companies face some of the most stringent product marketing requirements in the US, the regulatory ...
"Our significant showcase at ASH this year reflects Parexel’s specialized scientific and medical expertise in hematology and our commitment to partnering with leading biopharma sponsors to advance ...
The Life Sciences BPO Market is expanding rapidly, driven by rising R&D costs, increasing regulatory complexities and the growing need for operational efficiency across pharma and biotech sectors.
Nigeria becomes the 24th out of only 25 NRAs worldwide recognised for commitment to globally harmonised pharmaceutical standards ...
SIGA Technologies, Inc. faces revenue uncertainty and dependency risks despite strong profits. Click for my updated look at ...
The Global Life Sciences BPO Market Size projected to grow at a CAGR of 7.50% from 2026 to 2032, according to a new report published by Verified Market Research®. The report reveals that the market ...
Thailand and Myanmar expressed a mutual desire to see peace and development in Thai-Myanmar border areas, and concurred that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results